The findings that changes in ZRF1 activity are linked to different types of cancer such as acute myeloid leukemia (AML)38, gastric carcinoma39, breast carcinoma40 and head and neck squamous cell carcinoma (HNSCC)41 highlights the connection of ZRF1 to genome stability. This evidence concerns the gene DNAJC2 and cancer.